Search results for "PEDIATRIA"

showing 10 items of 692 documents

Barriers and incentives for Italian paediatricians to become smoking cessation promoters: a GARD-Italy Demonstration Project

2020

Background: Paediatricians rarely devote any time to screening and treatment for parental tobacco use. The present project is part of a Global Alliance against Chronic Respiratory Diseases (GARD)-Italy Demonstration Project, aimed to increase the skills of primary care physicians and paediatricians as "promoter of smoking cessation". The aims of this study were: (I) to identify latent classes of barriers and incentives for smoking cessation counseling among paediatricians using latent class analysis (LCA); (II) to investigate risk factors for inclusion into the identified classes. Methods: In 2018, 1,500 Italian paediatricians were invited to complete an online survey on passive smoke expos…

Pulmonary and Respiratory Medicinebarriers; incentives; latent class analysis (LCA); paediatricians; smoking cessationmedicine.medical_specialtyincentivesmedicine.medical_treatmentmedia_common.quotation_subjectbarriersOriginal Article of GARD SectionLatent class analysis (LCA);Settore MED/38 - Pediatria Generale E SpecialisticaLatent class analysis (LCA)medicinepaediatricians;Multinomial logistic regressionmedia_commonbusiness.industryAddictionpaediatricianLatent class modelWork experienceincentivePassive Smoke Exposuresmoking cessationFamily medicineRespondentbarrierSmoking cessationbusinessInclusion (education)paediatricians
researchProduct

Reasons for inadequate asthma control in children: an important contribution from the “French 6 Cities Study”

2012

Asthma represents the most common chronic illness in children [1] and an important clinical and public health problem. In fact, diagnosing and treating asthma in children still remain a challenge. There is evidence that children with asthmatic symptoms are often undiagnosed and undertreated [2]. Considering the prevalence of childhood asthma and its associated burden, it is mandatory to obtain an optimal control of the disease and improving outcomes for patients [3]. To achieve this goal, guidelines were published with indications about medication use, control of the environment and health education. Unfortunately, evidence exists that guidelines recommendations are often not applied within…

Pulmonary and Respiratory Medicinelcsh:RC705-779medicine.medical_specialtyPediatricsbusiness.industryPublic healthPsychological interventionDiseaselcsh:Diseases of the respiratory systemSettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaseAsthmaEditorialSettore MED/38 - Pediatria Generale E SpecialisticachildrenWheezeHealth caremedicineHealth educationRespiratory functionmedicine.symptombusinessIntensive care medicineAsthma; childrenAsthmaMultidisciplinary Respiratory Medicine
researchProduct

Third-hand smoke exposure and health hazards in children

2013

Smoking still represents a huge public health problem. Millions of children suffer the detrimental effects of passive smoking. An increasing number of countries have recently issued laws to regulate smoking in public places. Instead, homes remain a site where children are dangerously exposed to environmental tobacco smoke (ETS). The combination of tobacco smoke pollutants which remain in an indoor environment, the so-called ‘third-hand smoke’ (THS), represent a new concept in the field of tobacco control. THS consists of pollutants that remain on surfaces and in dust after tobacco has been smoked, are re-emitted into the gas-phase, or react with other compounds in the environment to form se…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPassive smokinglcsh:MedicineSettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.disease_causeTobacco smokeHazardous SubstancesThird-hand smokeSettore MED/38 - Pediatria Generale E SpecialisticaEnvironmental tobacco smokeEnvironmental healthmedicineHumansEnvironmental tobacco smoke Children Lung development Asthma Tobacco control Indoor environment Third-hand smoke.Active smokingThird-hand smokeChildChildrenSmokebusiness.industryPublic healthTobacco controllcsh:RIndoor environmentThird-hand smoke.AsthmaHuman exposureLung developmentTobacco Smoke PollutionTobacco controlCardiology and Cardiovascular Medicinebusiness
researchProduct

The value of FeNO measurement in childhood asthma: uncertainties and perspectives

2013

Asthma is considered an heterogeneous disease, requiring multiple biomarkers for diagnosis and management. Fractional exhaled nitric oxide in exhaled breath (FeNO) was the first useful non-invasive marker of airway inflammation in asthma and still is the most widely used. The non-invasive nature and the relatively easy use of FeNO technique make it an interesting tool to monitor airway inflammation and rationalize corticosteroid therapy in asthmatic patients, together with the traditional clinical tools (history, physical examination and lung function tests), even if some controversies have been published regarding the use of FeNO to support the management of asthma in children. The problem…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPediatricsPopulationexhaled nitric oxide asthma children pollutionContext (language use)ReviewDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioPulmonary function testing03 medical and health sciences0302 clinical medicineSettore MED/38 - Pediatria Generale E Specialisticachildrenmedicinepollution030212 general & internal medicineIntensive care medicineeducationFENO; Childhood asthmaAsthmaeducation.field_of_studybusiness.industryConfoundingasthmarespiratory systemmedicine.disease3. Good healthrespiratory tract diseases030228 respiratory systemExhaled nitric oxideexhaled nitric oxideBiomarker (medicine)businessMultidisciplinary Respiratory Medicine
researchProduct

Prevalencia y riesgo anual de infección tuberculosa en adolescentes de 12 a 16 años de la ciudad de Valencia. Utilidad de los nuevos métodos de inmun…

2015

INTRODUCCIÓN: La tuberculosis (TB) es un problema de salud pública, por su gran incidencia, prevalencia y mortalidad. Por ello es importante crear estrategias de control de la enfermedad, y hacer un correcto diagnóstico y tratamiento de la infección. Los países con peor infraestructura sanitaria y más pobreza, concentran más casos. Sin embargo, España tiene mayor incidencia de la esperada para su nivel de desarrollo. La evolución de las tasas en la Comunidad Valenciana, es similar a las globales de España, pero en los últimos años ha habido un aumento del número de casos en extranjeros, coincidiendo con el incremento de la inmigración. La prueba de la tuberculina (PT) se utiliza para el dia…

QuantiFERON-TBIGRAsensitinasprevalenciaadolescentesPEDIATRIAMICROBIOLOGIAmicobacterias no tuberculosasinmunodiagnósticodiagnósticoSALUD PUBLICAriesgo anual de infeccióninterferon gammatuberculosisRAIinfección tuberculosaValenciaMycobaterium aviuminterferon gamma release assayT-SPOT.TBEPIDEMIOLOGIA
researchProduct

A survey on features of allergic rhinitis in children

2013

Objective: A number of epidemiologic studies evaluated the prevalence of allergic rhinitis (AR), but few data are available on its different clinical presentations. We addressed this survey to assess the features of AR in children and adolescents. Methods: Thirty-five centers in Italy included 2623 pediatric patients with rhinitis, of whom 2319 suffered from AR, while 304 had other kinds of rhinitis. For each patient a standardized questionnaire was filled in, including ARIA classification, the duration of symptoms, the allergen identified as clinically relevant, the co-morbidities, the kind of treatment, the response to treatment, the satisfaction with the treatment, and the feasibility of…

QuestionnairesMalePediatricsmedicine.disease_causeAdrenal Cortex HormoneAllergic rhinitisDrug treatmentAllergenAdrenal Cortex HormonesGrass pollenSurveys and QuestionnairesChildRhinitisAllergen immunotherapybiologyMedicine (all)PyroglyphidaeGeneral MedicineDust mitesResponse to treatmentPhenotypesPhenotypeItalyChild PreschoolFemaleAdolescent; Adrenal Cortex Hormones; Animals; Child; Child Preschool; Female; Histamine Antagonists; Humans; Italy; Male; Rhinitis Allergic Seasonal; Pyroglyphidae; QuestionnairesHistamine AntagonistHumanallergen immunotherapy; phenotypes; aria classification; allergic rhinitis; drug treatmentmedicine.medical_specialtyAllergen immunotherapyAdolescentHistamine AntagonistsAnimals; Questionnaires; Humans; Pyroglyphidae; Child; Italy; Adrenal Cortex Hormones; Child Preschool; Histamine Antagonists; Rhinitis Allergic Seasonal; Adolescent; Female; MaleAllergen immunotherapy; Allergic rhinitis; ARIA classification; Drug treatment; PhenotypesAllergicmedicineAllergic rhinitiAnimalsHumansPreschoolSettore MED/38 - Pediatria Generale e SpecialisticaSeasonalbusiness.industryAnimalQuestionnairePyroglyphidaeRhinitis Allergic Seasonalbiology.organism_classificationDermatologyClinical trialMulticenter studyARIA classificationbusiness
researchProduct

LA RMN NEL FOLLOW UP DELLA FUNZIONALITA’ GONADICA NELLE ADOLESCENTI CON S. DI TURNER

2012

RMN IPOGONADISMO SINDROME DI TURNERSettore MED/38 - Pediatria Generale E Specialistica
researchProduct

Global (pharmacological and non pharmacological) prevention of RSV infection

2012

RSV preventionSettore MED/38 - Pediatria Generale E Specialistica
researchProduct

Un problema emergente: il rachitismo carenziale nei bambini adottati dall’estero.

2006

Rachitismo.Settore MED/38 - Pediatria Generale E SpecialisticaBambino adottato
researchProduct

Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry

2022

© 2022 Elsevier Inc.Background/objectives: Long-term efficacy and safety of tocilizumab (TCZ) in adult-onset Still's disease (AOSD) mostly derive from small case series. Herein we report a registry-based study investigating TCZ efficacy and safety in a cohort of patients with AOSD evaluated by clinical and serum inflammatory markers as well as drug retention rate analysis. Methods: This is an international multicentre study analyzing data from patients with AOSD regularly enrolled in the AIDA registry. TCZ efficacy was evaluated between baseline and last follow-up assessment in terms of changes in the Pouchot score and laboratory findings. Drug-retention rate was estimated by the Kaplan-Mei…

RegistrieAdultMaleSettore MED/16 - REUMATOLOGIAInterleukin-6Innovative biotechnologiesTocilizumabAdult-onset Still's diseaseAntibodies Monoclonal HumanizedPersonalized medicineAdult-onset Still's disease; Innovative biotechnologies; Interleukin-6; Personalized medicine; TocilizumabSettore MED/38 - Pediatria Generale E SpecialisticaAnesthesiology and Pain MedicineRheumatologyInnovative biotechnologieStill's diseaseHumansFemaleRegistriesImmunotherapyTocilizumab.Still's Disease Adult-OnsetHuman
researchProduct